ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 9 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $316,000 | +35.0% | 2,872,372 | +192.1% | 0.00% | – |
| Q2 2020 | $234,000 | +2027.3% | 983,512 | +3101.0% | 0.00% | – |
| Q3 2019 | $11,000 | -88.2% | 30,725 | -92.4% | 0.00% | – |
| Q2 2019 | $93,000 | -89.6% | 403,679 | -0.7% | 0.00% | -100.0% |
| Q1 2018 | $895,000 | +639.7% | 406,593 | +562.9% | 0.00% | – |
| Q4 2017 | $121,000 | – | 61,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clear Creek Financial Management, LLC | 400,000 | $95,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 12,254,080 | $2,915,000 | 0.02% |
| jvl associates llc | 58,500 | $14,000 | 0.02% |
| RETIREMENT INCOME SOLUTIONS, INC | 32,060 | $7,000,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 59,600 | $14,000 | 0.00% |
| Ranch Capital Advisors Inc. | 10,000 | $1,000 | 0.00% |
| UBS Group AG | 54,974 | $13,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 225 | $54,000 | 0.00% |
| Krilogy Financial LLC | 10,000 | $2,000 | 0.00% |